Cookies help us improve your website experience.
By using our website, you agree to our use of cookies.

Latest Post

May 14, 2019

Industry Trends in China: The Generic Consistency Evaluation

In China, the industrial and regulatory landscape has been evolving rapidly – and in particular as it relates to generic drug products. In 2015, the China State Council announced Opinions on Reforming the Review and Approval System for Drugs and Medical Devices (No. 44). At this same time, a series of reforms were announced by the National Drug Administration of China (formerly the China Food and Drug Administration, CFDA) to upgrade the pharmaceutical industry by raising marketed products to international standards in terms of quality, safety and efficacy.
Lynn Yao

Lynn Yao

Manager, Scientific Affairs, CN

Previous Posts
Introducing Integrated Solutions

May 02, 2019

FDA Guidance Affecting cGMP Compounding Pharmacies (503Bs)

Amy Kim

Amy Kim

Sr. Specialist, Scientific Communications, SA & TS

SmartDose Platform

April 26, 2019

Overcoming Challenges Associated with Biologic Drug Formulation and Development

Victoria Morgan

Victoria Morgan

Director, Segment Marketing, Global Biologics

What's New In the West Knowledge Center

April 16, 2019

What’s New in the Knowledge Center?

Tara Haarlander

Tara Haarlander

Sr. Specialist, Scientific Communications

Leo Posner of Johnson & Johnson presenting at the PDA Combo Workshop

April 03, 2019

The Challenges of Combination Products

Fran DeGrazio

Fran DeGrazio

VP, Technical Services and Scientific Affairs

SmartDose Injection Platform in Use

October 16, 2018

Medical Device User Fee Rates

Ana Ladino

Ana Ladino

Director, Regulatory Affairs

Load more